FDA clears Denali drug in ‘clear step’ for rare disease biotechs

BioPharma Dive

The approval of Denali s Hunter syndrome treatment, Avlayah, comes after a series of drug rejections and delays that had led to criticism of the FDA s stance on rare disease therapies.

RegulatoryRare DiseaseRead full story